🎉 M&A multiples are live!
Check it out!

Tempo Scan Pacific Valuation Multiples

Discover revenue and EBITDA valuation multiples for Tempo Scan Pacific and similar public comparables like Armata Pharmaceuticals, Vivoryon Therapeutics, and Pharming.

Tempo Scan Pacific Overview

About Tempo Scan Pacific

PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.


Founded

1970

HQ

Indonesia
Employees

4.5K+

Financials

Last FY Revenue $824M

Last FY EBITDA $140M

EV

$498M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Tempo Scan Pacific Financials

See Tempo Scan Pacific valuation multiples based on analyst estimates

Tempo Scan Pacific P&L

In the most recent fiscal year, Tempo Scan Pacific reported revenue of $824M and EBITDA of $140M.

Tempo Scan Pacific expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Tempo Scan Pacific valuation multiples based on analyst estimates
NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $824M XXX XXX XXX
Gross Profit XXX $313M XXX XXX XXX
Gross Margin XXX 38% XXX XXX XXX
EBITDA XXX $140M XXX XXX XXX
EBITDA Margin XXX 17% XXX XXX XXX
EBIT XXX $109M XXX XXX XXX
EBIT Margin XXX 13% XXX XXX XXX
Net Profit XXX $87.4M XXX XXX XXX
Net Margin XXX 11% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Tempo Scan Pacific Stock Performance

Tempo Scan Pacific has current market cap of IDR 11.59T (or $700M), and EV of IDR 8.24T (or $498M).

Market Cap Evolution

Tempo Scan Pacific Stock Data

As of October 17, 2025, Tempo Scan Pacific's stock price is IDR 2570 (or $0).

See Tempo Scan Pacific trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$498M $700M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Tempo Scan Pacific Valuation Multiples

Tempo Scan Pacific's trades at 0.6x EV/Revenue multiple, and 3.6x EV/EBITDA.

See valuation multiples for Tempo Scan Pacific and 15K+ public comps

Tempo Scan Pacific Financial Valuation Multiples

As of October 17, 2025, Tempo Scan Pacific has market cap of $700M and EV of $498M.

Equity research analysts estimate Tempo Scan Pacific's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Tempo Scan Pacific's P/E ratio is not available.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $700M XXX $700M XXX XXX XXX
EV (current) $498M XXX $498M XXX XXX XXX
EV/Revenue n/a XXX 0.6x XXX XXX XXX
EV/EBITDA n/a XXX 3.6x XXX XXX XXX
EV/EBIT n/a XXX 4.5x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX 8.0x XXX XXX XXX
EV/FCF n/a XXX 6.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Tempo Scan Pacific Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Tempo Scan Pacific Margins & Growth Rates

Tempo Scan Pacific's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $45K for the same period.

Tempo Scan Pacific's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Tempo Scan Pacific's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Tempo Scan Pacific and other 15K+ public comps

Tempo Scan Pacific Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX 17% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $45K XXX XXX XXX
S&M Expenses to Revenue XXX XXX 14% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 0% XXX XXX XXX
Opex to Revenue XXX XXX 25% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Tempo Scan Pacific Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Tempo Scan Pacific M&A and Investment Activity

Tempo Scan Pacific acquired  XXX companies to date.

Last acquisition by Tempo Scan Pacific was  XXXXXXXX, XXXXX XXXXX XXXXXX . Tempo Scan Pacific acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Tempo Scan Pacific

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Tempo Scan Pacific

When was Tempo Scan Pacific founded? Tempo Scan Pacific was founded in 1970.
Where is Tempo Scan Pacific headquartered? Tempo Scan Pacific is headquartered in Indonesia.
How many employees does Tempo Scan Pacific have? As of today, Tempo Scan Pacific has 4.5K+ employees.
Is Tempo Scan Pacific publicy listed? Yes, Tempo Scan Pacific is a public company listed on IDX.
What is the stock symbol of Tempo Scan Pacific? Tempo Scan Pacific trades under TSPC ticker.
When did Tempo Scan Pacific go public? Tempo Scan Pacific went public in 1994.
Who are competitors of Tempo Scan Pacific? Similar companies to Tempo Scan Pacific include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Tempo Scan Pacific? Tempo Scan Pacific's current market cap is $700M
Is Tempo Scan Pacific profitable? Yes, Tempo Scan Pacific is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.